NCT04864171Recruiting
REASSURE-NIRS Registry
REvelation of PAthophySiological PhenotypeS of VUlneRable Lipid-Rich PlaquE on Near-InfraRed Spectroscopy: REASSURE-NIRS
Source: ClinicalTrials.gov · Last updated 15 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
RESSURE-NIRS registry is designed to investigate clinical and pathophysiological characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease. This is an on-going multi-center prospective registry in Japan.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 24 Apr 2021
- Start date
- 9 Oct 2018
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- National Cerebral and Cardiovascular Center, Japan
- Diseases
- Coronary artery disease
- NCT number
- NCT04864171
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 9 Oct 2018 to the primary completion date, 31 Dec 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- poor quality of NIRS images
Who the study is looking for
- patients with coronary artery disease clinical indication for coronary angiography and/or percutaneous coronary intervention visualization of coronary lesions with NIRS
Age in the registry: 20 years to 95 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Miyazaki Medical Association Hospital Coordinator of this site? Confirm its status | Miyazaki | Japan | Recruiting |
| National Cerebral & Cardiovascular Center Coordinator of this site? Confirm its status | Suita | Japan | Recruiting |
Related publications
- Lipidic contents within calcified plaques: Characteristics and response to LDL-C<55 mg/dL on multi-modality imaging.Atherosclerosis · 2026 · PMID 41651577
- Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.Atherosclerosis · 2022 · PMID 35450750
This page is information, not medical advice. Discuss any trial with your doctor.